Atropos HealthA company that translates clinical data from practice into Real-World evidence has announced a partnership with Databricks, a Databricker and AI provider.
By expanding the Databricks Data Intelligence platform and the use of Delta sections, Atropos Health is able to enable clinics and researchers to create useful insights to increase the discoveries of medicines and reduce the time from symptom to treatment.
In a statement, Atropos Health said that it uses Delta parts to open and link data sets in its network, which contains more than 300 million patient records, including oncological data.
Delta Sharing is the open-source approach to Databricks with which customers can share live data on platforms, clouds and regions with security and governance.
Atropos Health and Databricks are aimed at picking up “New opportunities in health care and life sciences” by offering Geneva OS (generative evidence gear system) and the Atropos Evidence Network, the combining of the Real-World evidence Health with Databricks.
Michael Sanky, vice -president of health care and life sciences GTM at Databricks, said that his company was invested in bringing technological solutions for every industry, including working with partners such as Atropos Health.
“Atropos Health is an example of the transforming potential of building on Databricks, and it is incredible to view their adoption at organizations in health care and life sciences that are enthusiastic about using the full power of their data,” ” Sanky said.
The larger trend
In April, Atropos went one Strategic partnership with OntaDa, an McKesson company that is involved in community discology.
Oncology Network, a complete subsidiary of McKesson, is linked to the US Oncology Network, which provides real -time data, insights and research into how cancer is treated in a community.
The collaboration is intended to strengthen the use cases for clinicians, researchers and health care leaders to design care protocols, to promote precision medicine and to create new treatments in oncology.
Atropos entered into a partnership with Emory Healthcare. The health system set a program that wants to promote patient care by answering clinical questions in real time using the Atropos platform.
With the Atropos Evidence Network, Emory users can carry out studies for national data sets and local emory data.
Doctors can also use the green button from Atropos to gain access to evidence, generate results through supervised evidence development or a fully automated generative AI version (chatrwd).
In January, Atropos collaborated with XCures to use RWE -based insights to support patient care, and Atropos collaborated with Merck to generate RWE, replicate studies and produce rapid insights and analyzes based on data from the real world.
Last year, Databricks achieved a rating of $ 62 billion after collecting $ 10 billion in one Series J Financing Round. The company has collected a total of $ 8.6 billion.
Thray capitalAndreessen Horowitz, GIC, WCM Investment Management, Insight Partners and DST Global led De Ronde, with the participation of existing investors Ontario Teachers’ Pension Plan and new investors MGX, ICONIQ growth, Wellington Management and Sands Capital.
#Atropos #Health #Databricks #partner #sharing #data